Comprehensive Organ Protection & Cardiovascular Shield for Athletes 40+
Navigating intensive performance regimens over the age of 40 demands a sophisticated preventative strategy that shields the vascular tree, kidneys, and prostate. The Cycle Support 40+ Bundle by Driada Medical delivers a clinically validated defence mechanism engineered to neutralise the secondary physiological strains caused by advanced steroid cycles. By combining the selective AT1 receptor blocker Telmisartan with the cardio-selective, nitric oxide-potentiating beta-blocker Nebivolol, this stack maintains baseline systemic blood pressure and manages left ventricular workload without attenuating athletic output, establishing an uncompromising foundation for mature bodybuilders seeking cardiovascular durability.
Endocrine manipulation frequently accelerates dyslipidemia and androgen-driven follicular or prostatic hypertrophy. This stack combats lipid anomalies using Ezetimibe to block intestinal NPC1L1 cholesterol absorption, while daily micro-dosed Tadalafil enhances endothelial microcirculation and alleviates pelvic floor tone. Concurrently, Finasteride blocks type II 5-alpha reductase to spare hair follicles and prevent benign prostatic hyperplasia. Designed to run smoothly alongside intensive injectable steroids, this all-in-one preventative stack ensures uncompromised longevity, optimal organ biomarkers, and consistent performance across heavy training phases.
Driada Cycle Support 40+ Bundle Components
- 1 × Sartanos 20 mg (Telmisartan) | 20mg/tab - 100tabs
- 1 × Nebivolol 5mg (Nebimax-5) (50 tabs, 5 Blisters) | 5 mg per tab / 50 tabs
- 1 × Ezetimibe 10mg (Ezzitry-10) (50 tabs, 5 Blisters)
- 1 × Cialyn (Tadalafil) - Driada | 20tab| 5mg/tab
- 1 × Finastelad 1 mg (Finasteride) | 50 Tabs
Weekly Protocol & Dosing Architecture (Weeks 1–12)
| Compound | Pack Quantity | Recommended Dosage | Duration (Weeks) |
|---|
| Sartanos 20 mg (Telmisartan) | 20mg/tab - 100tabs | 1 × | 20–40 mg/day for blood pressure & kidney protection | 1–12 |
| Nebivolol 5mg (Nebimax-5) (50 tabs, 5 Blisters) | 5 mg per tab / 50 tabs | 1 × | 2.5–5 mg/day for resting heart rate & endothelial NO support | 1–12 |
| Ezetimibe 10mg (Ezzitry-10) (50 tabs, 5 Blisters) | 1 × | 10 mg/day for LDL cholesterol reduction on cycle | 1–12 |
| Cialyn (Tadalafil) - Driada | 20tab| 5mg/tab | 1 × | 5 mg/day for prostate health & vascular blood flow | 1–12 |
| Finastelad 1 mg (Finasteride) | 50 Tabs | 1 × | 1–1.25 mg/day for DHT hair & prostate protection | 1–12 |
Administration Schedule & Biomarker Management Protocol
Administering this preventative shield requires consistent circadian-aligned oral timing to match the respective terminal half-lives of each agent. Sartanos (Telmisartan) is dosed at 20–40 mg each morning alongside Nebimax-5 (Nebivolol) at 2.5–5 mg to stabilise vascular tone and modulate resting pulse without blunting exercise-induced tachycardia. During rigorous phases involving harsh compounds or oral steroids, add Ezzitry-10 (Ezetimibe) at 10 mg with your first whole-food meal to curb lipid absorption. Daily administration of 5 mg Cialyn (Tadalafil) and 1 mg Finastelad (Finasteride) ensures persistent eNOS activation and constant systemic 5-AR suppression throughout your active cycle.
Consistent biomarker tracking is mandatory when running heavy protocols. Regularly perform comprehensive metabolic panels and dedicated lipid tests to monitor your liver enzymes, LDL-C/HDL-C ratio, hematocrit, and renal filtration markers. While this stack protects your cardiovascular and internal organs during blast phases, preparing your endocrine system for post-cycle recovery is essential. Integrating dedicated ready PCT stacks containing SERMs like Enclomiphene or Tamoxifen following cycle cessation facilitates rapid hypothalamic-pituitary-gonadal axis restoration while retaining the protective physiological adaptations developed on cycle.
Key Health Advantages of the Cycle Support 40+ Stack
- Targeted Cardiovascular & Blood Pressure Control: Telmisartan blocks angiotensin II AT1 receptors to protect renal vasculature, while Nebivolol selectively enhances endothelial nitric oxide bioavailability to regulate resting heart rate and arterial stiffness.
- Advanced Lipid & Arterial Plaque Defence: Ezetimibe selectively inhibits intestinal cholesterol uptake via the NPC1L1 transporter, mitigating the atherogenic LDL-C elevations commonly triggered by exogenous androgens.
- Dual-Action Prostate & Microvascular Support: Daily low-dose Tadalafil induces cyclic GMP-mediated vasodilation to support microcirculation and pelvic perfusion, drastically lowering lower urinary tract symptoms.
- Follicular & Androgen Receptor Shield: Finasteride downregulates circulating dihydrotestosterone (DHT) levels by inhibiting 5-alpha reductase, safeguarding sensitive hair follicles against androgenic alopecia and blunting prostatic enlargement.
Frequently Asked Questions
Why combine Telmisartan with Nebivolol instead of using standard blood pressure medications?
Telmisartan uniquely combines angiotensin receptor blockade with partial PPAR-gamma agonism, improving insulin sensitivity and protecting renal tubules. Nebivolol is a third-generation beta-1 selective blocker that triggers endothelial nitric oxide release, stabilising resting heart rate without causing the bronchial constriction, fatigue, or athletic performance deficits typical of non-selective beta-blockers.
Will Finasteride reduce the anabolic muscle gains from my cycle?
No, Finasteride selectively inhibits the 5-alpha reductase enzyme responsible for converting systemic testosterone into dihydrotestosterone (DHT). Skeletal muscle tissue contains virtually no 5-alpha reductase; anabolic growth is mediated directly by testosterone binding to muscular androgen receptors. Finasteride preserves your hair follicles and prostate without negatively altering muscular hypertrophy.
How does Ezetimibe protect cardiovascular health during intense androgen usage?
Anabolic steroids often elevate hepatic lipase, driving down protective HDL-C and escalating atherogenic LDL-C. Ezetimibe uniquely halts the intestinal absorption of dietary and biliary cholesterol through the NPC1L1 transporter. This lowers circulating LDL-C and apolipoprotein B levels, helping prevent systemic arterial plaque deposition throughout your cycle.
Should I continue taking this cycle support bundle during my Post-Cycle Therapy (PCT)?
Yes, continuing Telmisartan, Nebivolol, and low-dose Tadalafil throughout your post-cycle recovery phase is highly beneficial. It maintains optimal blood pressure, reduces residual organ strain, and supports endothelial blood flow while your natural testosterone recovers, ensuring your cardiovascular system stabilizes as hormonal homeostasis is restored.
Consult an endocrinologist or qualified physician prior to initiating this protocol. Periodic monitoring of blood pressure, full lipid panels, renal function (creatinine, eGFR), hepatic enzymes, and serum DHT is strongly recommended. Keep stored in a cool, dry place out of reach of children.
Telmisartan 20 mg + Nebivolol 5 mg + Ezetimibe 10 mg + Tadalafil 5 mg + Finasteride 5 mg, Driada Medical
